PMID: 8947336Nov 1, 1996Paper

Significance of indoor environment for the development of allergic symptoms in children followed up to 18 months of age

Allergy
D GustafssonN I Kjellman

Abstract

The development of symptoms possibly related to allergy or other forms of hypersensitivity was studied in a group of 638 children on two occasions: when the children were 3 and 18 months of age. Standardized questions were used to collect basic information about the child, technical characteristics of the home, and the mother's perception of the indoor climate. All reported exposure factors were analyzed in relation to the child's symptoms at 18 months of age, by logistic regression techniques. A family history of atopy was associated with a high incidence of most of the investigated symptoms. Attendance at a day nursery before 18 months of age increased the risk of recurrent colds and the need for several courses of treatment with antibiotics. If the mother smoked, the children more often suffered from protracted coughing episodes. If the child has a sibling, the risk of developing a wheeze, repeated colds, and the need for antibiotic treatment increased. No building factors, such as size of the home, heating and ventilation system, type of foundation, dampness, or presence of wall-to-wall carpets, showed a significant correlation to symptoms reported in the children. However, if the mothers reported symptoms that are often co...Continue Reading

References

Aug 1, 1992·The Journal of Allergy and Clinical Immunology·S H Arshad, D W Hide
Aug 1, 1992·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R G RuizJ F Price
Jan 1, 1991·Allergy·J Korsgaard, M Iversen
May 11, 1991·BMJ : British Medical Journal·C F RobertsonP D Phelan
Sep 1, 1990·The Journal of Allergy and Clinical Immunology·D R Ownby
Jan 1, 1989·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N Aberg
Oct 1, 1989·Archives of Disease in Childhood·M L BurrE Vaughan-Williams
May 1, 1988·Archives of Disease in Childhood·S AndraeN I Kjellman
Apr 1, 1987·Archives of Disease in Childhood·J J CogswellJ Alexander
May 1, 1982·Archives of Disease in Childhood·S CronerA Roth
Sep 1, 1980·Clinical Allergy·F BjörksténV Koski
Apr 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·D P Strachan
Jun 1, 1995·Archives of Disease in Childhood·L BråbäckB Björkstén
Mar 12, 1994·BMJ : British Medical Journal·E von MutiusH H Thiemann
Feb 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M WickmanG Pershagen
Sep 1, 1993·European Journal of Epidemiology·E RylanderL Nordvall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.